Riskpilot← Back to searchSign inGet full accessScanfarma Aktiebolag
ABActiveOrg 5560446402Völundsgatan 2Retail sale of other food · NACE 4727Est. 19443 employees
Revenue 2024
SEK 10,2M
+2% vs 2023
EBITDA margin
-31.1%
-541% vs 2023
Equity ratio
33.0%
Financial strength
Net profit 2024
SEK -3M
-950% vs 2023
| Revenue | SEK 10,2M | +2% |
| EBITDA | SEK -3,2M | -541% |
| Net profit | SEK -3M | -950% |
| Total assets | SEK 4,4M | -42% |
| Equity | SEK 1,4M | -68% |
| Employees | 3 | — |
Legal name
Scanfarma Aktiebolag
Org number
5560446402
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
8 december 1944
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall idka tillverkning av samt handel och agenturrörelse med farmaceutiska preparat, ävensom idka därmed förenlig verksamhet.
Address
Völundsgatan 2
Phone
+468308010
Email
oliver@scanfarma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 130 | 11 664 | 10 382 | 9 980 | 10 184 |
| Staff expenses | — | — | — | −2 354 | −1 846 |
| EBITDA | 241 | −180 | 556 | 719 | −3 170 |
| Depreciation & amort. | −0 | −0 | −0 | −3 | −26 |
| EBIT | 241 | −180 | 556 | 716 | −3 196 |
| Net financials | −4 | −1 | 2 | 34 | 6 |
| Profit before tax | 220 | −164 | 558 | 452 | −3 036 |
| Tax | −11 | −0 | −103 | −95 | — |
| Net profit | 209 | −164 | 455 | 357 | −3 036 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 475 | 7 535 | 8 000 | 7 515 | 4 395 |
| Equity | 3 837 | 3 673 | 4 128 | 4 485 | 1 449 |
| Long-term debt | 0 | 2 435 | 2 415 | 1 997 | 2 007 |
| Short-term debt | 4 621 | 1 427 | 1 457 | 879 | 938 |
| Total debt | 4 621 | 3 862 | 3 872 | 2 875 | 2 945 |
EBITDA margin
-31.1%
This company
15.8%
Market median
-297% vs market
20202024
Equity ratio
33.0%
This company
38.2%
Market median
+14% vs market
20202024
Return on equity
-209.5%
This company
18.4%
Market median
-1239% vs market
20202024
Net profit margin
-29.8%
This company
8.1%
Market median
-468% vs market
20202024
Asset turnover
2.32×
This company
1.12×
Market median
+107% vs market
20202024
Debt / equity
2.03×
This company
0.62×
Market median
-227% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KE Chief Auditor | Chief Auditor | 2025 |
CO Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (4) | ||
EK Chief Auditor | Chief Auditor | 2025 – 2025 |
BL Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
LM Chief Auditor | Chief Auditor | 2022 – 2025 |
CM Audit | Audit | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Aktiebolaget Rickardsvik
Scanfarma Aktiebolag Board members of Scanfarma Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Kristina Nelson Stavefeldt | Chief Auditor | 0 companies |
| Bodil Lindén | Chief Executive Officer | 0 companies |
| Lars Magnus Dahlgren | Chief Auditor | 0 companies |
| Claes Mikael Jennel | Audit | 0 companies |
| Karl Erik Kristoffer Saglind | Chief Auditor | 0 companies |
| Carl Oliver Källenfors | Chief Executive Officer | 0 companies |
| Jennifer Rebecca Aychouh Källenfors | Deputy Board Member | 0 companies |